Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study

Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional ev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Antonio Gallo, Philippe Giral, David Rosenbaum, Alessandro Mattina, Ali Kilinc, Alain Giron, Khaoula Bouazizi, Moussa Gueda Moussa, Joe-Elie Salem, Alain Carrié, Valérie Carreau, Sophie Béliard, Randa Bittar, Philippe Cluzel, Eric Bruckert, Alban Redheuil, Nadjia Kachenoura
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
R
Acceso en línea:https://doaj.org/article/f00835c77da9482894abb416cebc919c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f00835c77da9482894abb416cebc919c
record_format dspace
spelling oai:doaj.org-article:f00835c77da9482894abb416cebc919c2021-12-04T04:34:44ZMyocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study2352-396410.1016/j.ebiom.2021.103735https://doaj.org/article/f00835c77da9482894abb416cebc919c2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352396421005296https://doaj.org/toc/2352-3964Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional evaluation of heart chambers through cine sequences and for myocardial tissue characterization through late gadolinium enhancement (LGE) and T1 mapping images. We aimed to assess the prevalence of myocardial fibrosis in FH patients. Methods: Seventy-two asymptomatic subjects with genetically confirmed FH (mean age 49·24, range 40 to 60 years) were prospectively recruited along with 31 controls without dyslipidaemia matched for age, sex, BMI, and other cardiovascular risk factors. All underwent CMR including cine, LGE, pre- and post-contrast T1 mapping. Extracellular volume (ECV) and enhancement rate of the myocardium (ERM = difference between pre- and post-contrast myocardial T1, normalized by pre-contrast myocardial T1) were calculated. Findings: Five FH patients and none of the controls had intramyocardial LGE (p= 0·188). While no changes in Native T1 and ECV were found, post-contrast T1 was significantly lower (430·6 ± 55ms vs. 476·1 ± 43ms, p<0·001) and ERM was higher (57·44± 5·99 % vs 53·04±4·88, p=0·005) in HeFH patients compared to controls. Moreover, low post-contrast T1 was independently associated with the presence of xanthoma (HR 5·221 [1·04-26·28], p= 0·045). A composite score combining the presence of LGE, high native T1 and high ERM (defined as ≥ mean ± 1·5 SD) was found in 20·8% of the HeFH patients vs. 0% in controls (p<0·000, after adjustment for main confounders). Interpretation: CMR revealed early changes in myocardial tissue characteristics in HeFH patients, that should foster further work to better understand and prevent the underlying pathophysiological processes.Antonio GalloPhilippe GiralDavid RosenbaumAlessandro MattinaAli KilincAlain GironKhaoula BouaziziMoussa Gueda MoussaJoe-Elie SalemAlain CarriéValérie CarreauSophie BéliardRanda BittarPhilippe CluzelEric BruckertAlban RedheuilNadjia KachenouraElsevierarticleFamilial hypercholesterolemiacardiovascular imagingcardiac magnetic resonanceprimary preventiongenetic dyslipidaemiacardiovascular riskMedicineRMedicine (General)R5-920ENEBioMedicine, Vol 74, Iss , Pp 103735- (2021)
institution DOAJ
collection DOAJ
language EN
topic Familial hypercholesterolemia
cardiovascular imaging
cardiac magnetic resonance
primary prevention
genetic dyslipidaemia
cardiovascular risk
Medicine
R
Medicine (General)
R5-920
spellingShingle Familial hypercholesterolemia
cardiovascular imaging
cardiac magnetic resonance
primary prevention
genetic dyslipidaemia
cardiovascular risk
Medicine
R
Medicine (General)
R5-920
Antonio Gallo
Philippe Giral
David Rosenbaum
Alessandro Mattina
Ali Kilinc
Alain Giron
Khaoula Bouazizi
Moussa Gueda Moussa
Joe-Elie Salem
Alain Carrié
Valérie Carreau
Sophie Béliard
Randa Bittar
Philippe Cluzel
Eric Bruckert
Alban Redheuil
Nadjia Kachenoura
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
description Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional evaluation of heart chambers through cine sequences and for myocardial tissue characterization through late gadolinium enhancement (LGE) and T1 mapping images. We aimed to assess the prevalence of myocardial fibrosis in FH patients. Methods: Seventy-two asymptomatic subjects with genetically confirmed FH (mean age 49·24, range 40 to 60 years) were prospectively recruited along with 31 controls without dyslipidaemia matched for age, sex, BMI, and other cardiovascular risk factors. All underwent CMR including cine, LGE, pre- and post-contrast T1 mapping. Extracellular volume (ECV) and enhancement rate of the myocardium (ERM = difference between pre- and post-contrast myocardial T1, normalized by pre-contrast myocardial T1) were calculated. Findings: Five FH patients and none of the controls had intramyocardial LGE (p= 0·188). While no changes in Native T1 and ECV were found, post-contrast T1 was significantly lower (430·6 ± 55ms vs. 476·1 ± 43ms, p<0·001) and ERM was higher (57·44± 5·99 % vs 53·04±4·88, p=0·005) in HeFH patients compared to controls. Moreover, low post-contrast T1 was independently associated with the presence of xanthoma (HR 5·221 [1·04-26·28], p= 0·045). A composite score combining the presence of LGE, high native T1 and high ERM (defined as ≥ mean ± 1·5 SD) was found in 20·8% of the HeFH patients vs. 0% in controls (p<0·000, after adjustment for main confounders). Interpretation: CMR revealed early changes in myocardial tissue characteristics in HeFH patients, that should foster further work to better understand and prevent the underlying pathophysiological processes.
format article
author Antonio Gallo
Philippe Giral
David Rosenbaum
Alessandro Mattina
Ali Kilinc
Alain Giron
Khaoula Bouazizi
Moussa Gueda Moussa
Joe-Elie Salem
Alain Carrié
Valérie Carreau
Sophie Béliard
Randa Bittar
Philippe Cluzel
Eric Bruckert
Alban Redheuil
Nadjia Kachenoura
author_facet Antonio Gallo
Philippe Giral
David Rosenbaum
Alessandro Mattina
Ali Kilinc
Alain Giron
Khaoula Bouazizi
Moussa Gueda Moussa
Joe-Elie Salem
Alain Carrié
Valérie Carreau
Sophie Béliard
Randa Bittar
Philippe Cluzel
Eric Bruckert
Alban Redheuil
Nadjia Kachenoura
author_sort Antonio Gallo
title Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
title_short Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
title_full Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
title_fullStr Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
title_full_unstemmed Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
title_sort myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
publisher Elsevier
publishDate 2021
url https://doaj.org/article/f00835c77da9482894abb416cebc919c
work_keys_str_mv AT antoniogallo myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT philippegiral myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT davidrosenbaum myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT alessandromattina myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT alikilinc myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT alaingiron myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT khaoulabouazizi myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT moussaguedamoussa myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT joeeliesalem myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT alaincarrie myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT valeriecarreau myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT sophiebeliard myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT randabittar myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT philippecluzel myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT ericbruckert myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT albanredheuil myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
AT nadjiakachenoura myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy
_version_ 1718373005375045632